Clinical Trials Browser

Interventional × Adjuvants, Pharmaceutic × Genitourinary × Clear all

NCT02897765 2021-02-25

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Phase 1 Completed

DermatologicGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Skin Neoplasms

NCT02175212 2020-11-20

AADLPC

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma